rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Turn Therapeutics Inc.

TTRX · Nasdaq

Health CarePharmaceuticalsLeading

TTRX stood above a rising 150-day average in 18 of the last 19 weekly readings, including each of the last 18 weeks. It is 39.1% above that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation
Leading
Weeks in an uptrend
18 in a row
Industry in uptrend
31% -7 in 4 wk
Insider buys, 12 months
$308K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
29 (+9)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 18 of 19 weeks.

17 Apr – 16 Oct
26%36%46%Apr 26Jun 26Jul 26Sep 26Oct 26

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$184KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months9
Sale orders, 12 months0
Buyers · sellers3 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders29+9 on the quarter
New · exited11 · 2
Reported value$8.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
SteelPeak Wealth, LLCnew · filed 13 Jul 2026249,456$1.8M+249,456
IEQ CAPITAL, LLCnew · filed 11 Aug 2026227,396$1.7M+227,396
DDFG, Incadded · filed 28 Jul 2026107,829$787K+37,295+52.9%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 202674,301$542K+24,851+50.3%
Wellington Shields & Co., LLCunchanged · filed 10 Aug 202665,732$480K00.0%
MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 202660,551$442K-9,206−13.2%
BlackRock, Inc.new · filed 7 Aug 202638,591$282K+38,591
Aaron Wealth Advisors LLCnew · filed 16 Jul 202632,564$238K+32,564
Tamar Securities, LLCunchanged · filed 5 Aug 202630,000$219K00.0%
ROYAL BANK OF CANADAnew · filed 14 Aug 202628,250$206K+28,250
31 Dec 2025 – 30 Jun 2026
202529Dec 25Mar 26Jun 26

News

No headline names it lately.

Everyone who traded it

Andrew Gengos Company insiderDirector · last 4 Jun 20260 · 0
Arthur F. Golden Company insiderDirector · last 4 Jun 20263 · 0
Kent Edward Kester Company insiderDirector · last 4 Jun 20260 · 0
Martin William Dewhurst Company insiderDirector · last 4 Jun 20260 · 0
Bradley Evan Burnam Company insiderChief Executive Officer · last 28 May 20260 · 0
Beb Holdings, Llc Company insider10% owner · last 2 Apr 20260 · 0
Zuraiz Chaudhary Company insiderOfficer · last 1 Apr 20265 · 0
Abraham Chesed Company insiderOther · last 23 Oct 20251 · 0
Neilesh Shailesh Ghodadra Company insiderChief Medical Officer · last 8 Oct 20250 · 0

Same industry

PCRX Pacira BioSciencesLeading+46%
CORT Corcept TherapeuticsLeading+33%
ETON Eton PharmaceuticalsLeading+26%
AMRX Amneal PharmaceuticalsLeading+21%
ABBV AbbVieLeading+20%
TEVA Teva Pharmaceutical IndustriesLeading+20%
VTRS ViatrisLeading+16%
LLY Eli Lilly andLeading+15%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-95.1%
Share count trendFY 2025 · to 30 Mar 20261.2%
Cash and equivalentsFY 2025 · to 31 Dec 2025$4.0M

Analyst forecasts

No analyst forecasts yet.